Monday, June 23, 2025

Cipla Q3 Results: US sales beat expectations, while revenue, margin grow from last year

Date:

Shares of drugmaker Cipla Ltd. surged to the day’s high, gaining as much as 4% after the company’s December quarter results. The results were a beat across parameters.

Company Value Change %Change

Revenue for the quarter stood at ₹7,073 crore, which is a 7% growth from last year and also higher than the CNBC-TV18 poll of ₹6,870.2 crore.

Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) grew by 14% year-on-year to ₹1,989 crore, which was also higher than the CNBC-TV18 poll of ₹1,748 crore.

EBITDA margin for the period expanded by 200 basis points to 28% from 26% last year. For the first nine months of the financial year, Cipla’s EBITDA margin 26.9%, which is higher than the management guidance of 24.5% to 25.5% for the full year.

Net profit for the period also increased by 49% from the year-ago period to ₹1,570 crore. A CNBC-TV18 poll had pegged the figure at ₹1,175 crore.

Sales from the US market, where Cipla derives its majority revenue from declined by 2% from last year to $226 million. However, the figure was better than the CNBC-TV18 poll of $218 million.

Shares of Cipla are trading 4.2% higher post the results announcement at ₹1,454.5. The stock is still down 15% from its recent peak of ₹1,702.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Air India Kanishka bombing case: Canadian Police identifies mysterious man Mr X after 40 years

The Royal Canadian Mounted Police (RCMP) has finally identified...

Salesforce bets big on India for next phase of AI growth

Salesforce’s ambitions for a billion-strong digital agent workforce may...

Access Denied

Access Denied You don't have permission to access "...

US strikes on Iranian nuclear facilities may backfire strategically, experts warn

The recent US strikes on Iranian nuclear facilities could...